Today: 19 April 2026
GE Vernova stock price: GEV’s Friday dip leaves traders watching the Fed, jobs data next
28 February 2026
2 mins read

GE Vernova stock price: GEV’s Friday dip leaves traders watching the Fed, jobs data next

New York, Feb 28, 2026, 14:40 EST — The market is shut.

  • GE Vernova slipped 0.33% to finish Friday’s session at $873.60.
  • U.S. stocks dropped going into month-end, following a wholesale inflation print that came in above forecasts.
  • Coming up: U.S. jobs data lands March 6, followed by the Fed kicking off its March 17 meeting. GE Vernova’s dividend record date is set for the same day, with its earnings webcast slated for April 22.

GE Vernova Inc. slipped 0.33% to close at $873.60 Friday, trading as low as $853.34 and touching $876.36 during the day. Despite the drop, shares are still sitting roughly 5% above levels from a week ago, though they’ve come off Wednesday’s intraday peak of $894.93.

U.S. markets remain closed Saturday, leaving investors watching to see if the trend sticks once trading picks back up on Monday. GE Vernova has turned into a fast proxy for bets on power demand—positions there can swing sharply when rates or inflation grab headlines again.

This is relevant now, with the stock’s climb relying on long-cycle spending—turbines, grid equipment, power conversion. Markets tend to value those narratives based on anticipated Fed moves. Push rate cuts out, and suddenly that growth pitch starts to carry a steeper price tag.

Wall Street dropped across the board on Friday, with investors contending with fresh AI disruption worries, tariff jitters resurfacing, and ongoing geopolitical strains. Stronger-than-expected inflation data only added to the pressure. “To wrap up the month of February, we were reminded there are still some cracks out there,” said Ryan Detrick, chief market strategist at Carson Group. The Dow lost 1.05%, the S&P 500 shed 0.43%, and the Nasdaq slipped 0.92%. Reuters

Wholesale prices gained more ground in January, with the Producer Price Index up 0.5% and the “core” figure—which strips out food and energy—jumping 0.8%, according to Reuters. Ben Ayers, senior economist at Nationwide, said he sees the Fed holding steady at its March meeting, noting that the latest numbers signal stubborn inflation as markets wait for the government’s belated January PCE data on March 13. Reuters

GE Vernova’s wind business still faces significant risk. In late January, the company warned that missing the installation of 11 turbines at the Vineyard Wind offshore project could dent revenue by a low double-digit percentage and push losses to about $400 million. Even so, it bumped up its 2026 revenue forecast to $44 billion-$45 billion. CEO Scott Strazik told analysts GE Vernova is heading into 2026 with “significant momentum.” Reuters

Looking ahead, traders are eyeing March 17-18 for the Fed’s upcoming policy meeting—economic projections will be updated then. High-multiple industrials have moved with rate bets, and GE Vernova’s trading has mirrored that pattern.

The February U.S. jobs report lands March 6 at 8:30 a.m. Eastern—one more number that can jolt rate expectations.

GE Vernova’s board signed off on a quarterly dividend of $0.50 per share, set for payment on April 14 to investors holding shares as of March 17.

Looking ahead, the next key event is earnings. GE Vernova will hold its first-quarter 2026 earnings webcast on April 22. The stock’s trading close to its highs, so any new details on orders, margin trends, or wind execution could make or break the case for its current valuation.

Stock Market Today

  • Dave (DAVE) Shares Appear Overvalued After 197% Surge, Says Simply Wall St
    April 18, 2026, 9:08 PM EDT. Dave's share price jumped 197.5% over the past year, closing recently at $250.71. Despite strong gains, Simply Wall St's valuation models suggest the stock is significantly overvalued by about 473% based on intrinsic value calculations. The Excess Returns model, analyzing profits versus shareholder required returns, flags a large premium priced in. Dave scores just 2 out of 6 on valuation checks, raising caution amid its rapid one-year growth. Investors should weigh fundamentals against price surges to decide if optimism is already reflected in the current share price.

Latest article

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

18 April 2026
Definium Therapeutics shares rose to $22.68 after Stifel and Piper Sandler initiated coverage with Buy ratings, citing late-stage trials of DT120, an LSD-based tablet for anxiety and depression. The company will host an investor day April 22 in New York to discuss upcoming Phase 3 data. DT120 is in four pivotal studies, with top-line results expected through 2026. Johnson & Johnson and Compass Pathways are advancing rival clinic-based psychiatric drugs.
Chevron stock price faces Monday test after Leviathan shutdown, Hormuz shipping risks
Previous Story

Chevron stock price faces Monday test after Leviathan shutdown, Hormuz shipping risks

SoFi stock price slips to $17.76 after a 7% drop — what SOFI investors watch next week
Next Story

SoFi stock price slips to $17.76 after a 7% drop — what SOFI investors watch next week

Go toTop